US Bancorp’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

US Bancorp’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,099	Closed	-$58K	–	3817
2016 Q1	$58K	Sell	1,099 -85	-7%	-$6.28K	﹤0.01%	2314
2015 Q4	$135K	Buy	1,184 +205	+21%	+$22.6K	﹤0.01%	1895
2015 Q3	$115K	Sell	979 -1,197	-55%	-$156K	﹤0.01%	2005
2015 Q2	$168K	Buy	2,176 +1,614	+287%	+$106K	﹤0.01%	1853
2015 Q1	$33K	Sell	562 -744	-57%	-$31.6K	﹤0.01%	2743
2014 Q4	$42K	Buy	+1,306	New	+$39.2K	﹤0.01%	2618

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

US Bancorp's ANAC Position: Q2 2016 in Review

US Bancorp sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,099 shares — an estimated $58K sold.

US Bancorp first reported a position in ANAC in Q4 2014 and held it in 6 quarters. The position peaked at $168K in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

US Bancorp reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
US Bancorp sold 1,099 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $58K.
US Bancorp first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 6 quarters.
US Bancorp's ANACOR PHARMACEUTICALS INC COM position peaked at $168K in Q2 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on US Bancorp's 13F filing for Q2 2016, filed 10 Aug 2016.